MyFinsight
Home
Blog
About
Contact
syre: the balance sheet
Download
Download image
Prepaid expenses and
other current assets
$18,406K
Marketable securities
$421,301K
Cash and cash
equivalents
$64,897K
Total current assets
$504,604K
Total assets
$504,604K
Total liabilities,
convertible preferred stock...
$504,604K
Total stockholders
equity
$455,100K
Total liabilities
$49,504K
Accumulated deficit
-$1,065,105K
Accumulated other
comprehensive income
$791K
Additional paid-in capital
$1,363,581K
Non-current cvr liability
$3,230K
Total current
liabilities
$46,274K
Common stock, 0.0001
par value...
$13K
Series a non-voting
convertible preferred stock...
$9,395K
Series a non-voting
convertible preferred stock...
$146,425K
Related party accounts
payable-Related Party
$3,970K
Accrued and other
current liabilities
$23,827K
Cvr liability
$11,020K
Accounts
payable-Nonrelated Party
$7,457K
Back
Back
Balance Sheet
source: myfinsight.com
Spyre Therapeutics, Inc. (SYRE)
Spyre Therapeutics, Inc. (SYRE)